Alaunos Therapeutics Continues To Explore Potential Strategic Alternatives; Says Has Reduced Its Workforce By Approximately 80% To Date In Order To Streamline Organization And To Maximize Cash Runway
Alaunos Therapeutics Continues To Explore Potential Strategic Alternatives; Says Has Reduced Its Workforce By Approximately 80% To Date In Order To Streamline Organization And To Maximize Cash Runway
Alaunos Therapeutics继续探索潜在的战略替代方案；表示迄今为止已裁员约80％，以简化组织并最大限度地利用现金流
Alaunos continues to reduce spend and cost-savings measures taken to date are expected to extend its cash runway into the second quarter of 2024.
Alaunos继续减少支出，迄今为止采取的成本节约措施预计会将其现金流道延长至2024年第二季度。